The Mesothelioma Helping website was created to provide mesothelioma asbestos lung cancer patients, their families and friends with up-to-date information about asbestos mesothelioma cancer.
Monday, February 27, 2006
Strategic Alliance for GPCR Drug Discovery
Institute Pasteur Korea and Euroscreen Form Strategic Alliance for GPCR Drug Discovery
The Institute Pasteur Korea (IPK) and Euroscreen s.a. today announced a partnership to perform screening of G protein coupled receptors using internalization assays. The development at the Institute Pasteur Korea of a visual-based High Throughput Screening platform offers unique opportunities for the identification of drug candidates activating receptor internalization while Euroscreens receptor cell lines and GPCR library compounds will provide the initial direction and components for this drug discovery collaboration.
(PRWEB) February 27, 2006 -- The Institute Pasteur Korea (IPK) and Euroscreen s.a. today announced a partnership to perform screening of G protein coupled receptors using internalization assays. The development at the Institute Pasteur Korea of a visual-based High Throughput Screening platform offers unique opportunities for the identification of drug candidates activating receptor internalization while Euroscreens receptor cell lines and GPCR library compounds will provide the initial direction and components for this drug discovery collaboration.
This partnership takes thus advantage of both IPK expertise in the image analysis and HCS fields and Euroscreen competence in GPCR biology and Chemistry tools.
We are delighted to be working with Euroscreen s.a. on this GPCR Drug Discovery project. This partnership highlights the increasing interest in visual-based screening technologies to identify more selective drug candidates. It validates the screening approach we develop at IPK commented Dr. Thierry Christophe, Head of Screening Technologies and Pharmacology at Institute Pasteur Korea.
Collaborating with one of the Worlds leaders in the GPCR science sector signifies an important step in materialising IPKs innovative approach. We are enthusiastic to have found a highly competent partner in Euroscreen, to take HCS screening to the next level. added Dr. Ulf Nehrbass, Director and CEO of IPK.
This should provide our companies with a rapid, joint opportunity to develop drug candidates which selectively cause the internalization of GPCRs for their therapeutic action in vivo, said Dr. François Roman, the Head of Drug Development R&D at Euroscreen.
For further information, please contact:
Euroscreen s.a.: Tel: +32 71 348 500
Michel Detheux, Ph.D. Head of New Target & Drug Discovery Programs Initiatives
IPK
Thierry Christophe, Ph.D. Head of Screening Technologies and Pharmacology
About IP-Korea Institute Pasteur Korea (IP-Korea) has been created in 2004 with the strategic focus on enabling technologies and therapeutics development in disease models pertaining to public health. In order to meet this goal, IP-Korea was one of the few world research centers to develop High Throughput Screening facilities based on internal and collaborative development of new screening assays. Today IP-Korea can take advantage of the diversity of its research, including biology groups, image mining, new microscopy development or medicinal and nano chemistry.
IP-Korea is a part of the International Network of Pasteur Institutes, which allows IP-Korea the access to the research developed through the 28 other Institutes. In addition, IP-Korea has agreements with the French CNRS (Centre National pour le Recherche Scientifique), the KRICT (Korea Research Institute of Chemical Technology) and the KIST (Korea Institute of Science and Technology).
In the screening area, the goal of IP-Korea is to develop disease-based assays to visualize the physiological effect of the disease on the cellular level. To this end, IP-Korea has implemented the first worldwide uHTS platform from Evotec Technologies in a BSL-3 lab including an automatized confocal microscope (Opera) but also fluorescence/luminescence readers to perform High Content and HTScreens. For more information, please contact Dr. Philip Bernstein (email protected from spam bots)
Institute Pasteur Korea is a non-profit organization based in Seoul, South Korea.
About Euroscreen SA Euroscreen is a world leader in G-protein coupled receptors (GPCRs). The Company integrates its research expertise in this area with its patented high-throughput AequoScreen cellular assay platform to patent new GPCR targets and drug candidates.
The Company is building its own patent portfolio of GPCR targets and novel drug leads for licensing to biopharmaceutical companies, and to date has agreements with Amersham/GE Healthcare, Cephalon, ChemDiv, Evotec, ICOS, Merck & Co, Pfizer Inc, Solvay, Syngenta and UCB. Euroscreen has also established collaborations with numerous academic centers for access to licenses to help in making available its broad menu of GPCR-based products (recombinant cell lines and membrane preparations) and services (custom screening and cloning).
Euroscreen has grown significant and strong patent positions to protect many key drug targets for licensing. Such patents include CCR5, ChemR23, GPR43, GPR7/8, purinergic receptors (P2Y4, P2Y11 and P2Y13) and SHIP2 for type II diabetes. Euroscreen is able to offer intellectual property rights to companies for the development of therapeutic drugs that act through the above-mentioned targets. For more information regarding the Euroscreens portfolio, please contact Dr. Vincent Lannoy.
Euroscreen is a privately held company based in Brussels, Belgium with 80 employees of which 50 are in R&D.
# # #
Press Contact: Alfred Gray Company Name: EUROSCREEN Email: email protected from spam bots Phone: 716 308 6693 Website: www.euroscreen.com
There Is Unknown Information On Mesothelioma Treatments
JustMeso Offers Information on Treatment Options
JustMeso.com offers a plethora of information on treatment options for mesothelioma.
(I-Newswire) - Mesothelioma, the deadly disease that has been at the forefront of global medical and legal research for the last decade, is becoming increasingly susceptible to advanced treatment options. While the disease is not yet curable, if caught very early there are a wide range of rather divergent medical treatment options which have had substantial success in limiting the harmful effects of malignant mesothelioma.
While there are a number of treatment options available, often there is a great deal of unknown information regarding what the procedures available are and how they work. To that end, JustMeso.com ( http://www.JustMeso.com ) has provided comprehensive information about the disease, its causes, and now the treatment options available to those diagnosed at its website.
The site explains in great detail the many traditional and new treatments available to those diagnosed with malignant mesothelioma, such as surgical solutions, radiation, and chemotherapy. JustMeso.com breaks down each category into its component procedures as well as providing information on the extent of a procedure, its level of invasiveness, as well as an analysis of the costs and benefits of each specific procedure. This analysis includes summaries of information on the effectiveness and the scope of the effectiveness of a particular treatment option.
Combined, the information compiled by JustMeso.com in their treatment options section ( http://www.justmeso.com/treatment/ ), provides those diagnosed as well as their loved ones with a comprehensive resource from which they can attain a deeper understanding of the diseases as well as assess either own situation in light of the present treatment options available. This information can prove valuable insofar as it will give individuals an excellent overview of the options available to them. Through this information, individuals affected by mesothelioma can make more educated decisions about their own situation as well as be better situated to provide support for others. Of course, none of the information on JustMeso should be taken as medical advice, and a person should always consult their physician before taking treatment.
JustMeso.com ( http://www.JustMeso.com ) is based in the United States. It was created with the intent of providing a single resource for individuals seeking information about malignant mesothelioma.
If you have questions regarding information in this press release contact the company listed below. I-Newswire.com is a press release service and not the author of this press release. The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies / PR Agencies submit their press releases once per week/month or quarter, make sure check the official company website for accurate release dates as our site displays the I-Newswire.com distribution date only. We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for inaccuracies or omissions in that information or for actions taken in reliance on that information.
Mesothelioma Search Engine To Consolidate Medical and Legal Information
New lung cancer search engine provides information on medical and legal web sites for those researching this asbestos-caused killer cancer
Minneapolis, MN (NTS) February 23, 2006 On the one-year anniversary of the launch of their Vioxx Search Engine, Internet consulting firm Nielsen Technical Services today announced the launch of their Mesothelioma Search Engine.
Niche search engines or vertical search engines have increased in popularity, but the time and expense of creating and maintaining a search engine for a highly vertical segment of an available search audience is generally not a good investment financially. When asked about the financial viability of such a site, owner Chris Nielsen said, We have some interested parties that would like to be associated with us and are exploring those options, but will not compromise our values for the sake of making a buck. The massive amount of money the asbestos and mesothelioma lawyers are spending have resulted in a feeding frenzy which has spawned thousands of sites and millions of pages of fluff, trash, and recycled content. I admit our site is expected to carry ads at some point, but that is not the reason for creating the site.
Nielsen was then asked the reason for creating such a site. I just could not find a central source to go for information where sites were not bidding or competitively optimizing for position and search engine ranking. Search engines are fighting to maintain relevancy but they are having problems. Many scraper sites are only looking to get visitors that will click on ads to reach real content. If you try a search for mesothelioma it should be clear what the problem is.
As with their Vioxx medical and legal search engine, Mesothelioma Search Engine will carry no paid search engine results or paid inclusion of sites. The site has a form for visitors to suggest sites. The list of sites included in the index is posted on the site and clearly shows mesothelioma site owners if their site has been included. It is also available for download, a feature not offered by other search engines.
The company is indexing selected sites for those looking for more information such as patients, researchers, families, doctors, pharmacists, students, and those in the legal profession. This site is offered as a public service for those looking for information related to medical and legal information on mesothelioma lung cancer, or asbestos lung cancer for which there is no cure and is caused by exposure to asbestos fibers or asbestos dust.
About Nielsen Technical Services The company is based in Minneapolis, Minnesota and has been providing computer and software services since 1988. The Internet has transformed the company from a hardware services company into Internet consulting and specializes in search engine optimization.
Study Shows 20 Percent Suffer Chronic Pain While At-Home Relief is Available
A recent study indicates that 1 in 5 people with chronic pain do not seek medical assistance, according to the February issue of Mayo Clinic Proceedings. The National Fibromyalgia Association estimates 3% to 6% of the U.S. population is afflicted with debilitating pain. Thousands of Americans suffer from muscle tension left untreated while self-care toolkits are readily available to alleviate trigger point pain.
Gilbertsville, PA (PRWEB) February 24, 2006 -- Untreated pain has reached epidemic levels while a non-invasive, effective pain management solution is available. Physician administered trigger point therapy has been proven to reduce muscle pain; however, ongoing treatment can prove costly. The Pressure Positive Company has released affordable at-home, self-care toolkits to alleviate trigger point pain caused by muscle tension, Fibromyalgia and more.
The Pressure Positive Company has recently made available two at-home toolkits that capitalize on the benefits of trigger point therapy without the exorbitant cost of ongoing office visits. The Trigger Point Self-Care Toolkit includes the #1 best-selling book by Clair Davies, The Trigger Point Therapy Workbook, 2nd Edition, praised in the November 2005 issue of Dynamic Chiropractor for its concise instruction on daily management of trigger point pain. The Fibromyalgia Self-Care Toolkit contains the book Taking Charge of Fibromyalgia by Julie Kelly, MS, RN and Rosalie Devonshire, MSW, LCSW.
Both toolkits include self-care massage tool for reaching difficult points in the neck, back and shoulders. Kits also include tools that spare finger and thumb injuries during deep tissue massage. Both toolkits are only $57.95 each and are currently available online at: http://www.pressurepositive.com.
Renee Gladieux, Director of Sales and Marketing for The Pressure Positive Company, said, "Almost daily we receive phone calls from individuals who claim that our tools are the only things that have made a difference. We have hundreds of testimonials from people who have managed their pain and regained control of their lives. It's tremendously gratifying to be able to help so many people enjoy their lives again."
For over 27 years, The Pressure Positive Company has been designing and manufacturing unique massage therapy tools for the self-care of trigger point pain for use by health professionals and patients. Founder, Bernard Bun Gladieux has been at the forefront of the non-invasive pain management field since its inception.
Contact:
Renee Gladieux, The Pressure Positive Company Gilbertsville, PA 19525 800-603-5107 website: www.pressurepositive.com
# # #
Press Contact: Renee Gladieux Company Name: The Pressure Positive Email: email protected from spam bots Phone: 800-603-5107 Website: www.pressurepositive.com
Kennedy Statement On Asbestos Legislation Endorsed
Mesothelioma-attorney-case.com endorses kennedy statement on asbestos legislation.
Senator Edward Kennedy issued a key statement today regarding Bill S.852 the Fairness in Asbestos Injury Resolution Act of 2005. Kennedy's statements coincide with our previous opinion regarding the pending bill.
(I-Newswire) - Senator Edward Kennedy issued a key statement regarding Bill S.852 the Fairness in Asbestos Injury Resolution Act of 2005. Kennedy's statements coincide with our previous opinion regarding the pending bill.
The real crisis regarding asbestos exposure in the workplace is not potential litigation but the number of victims who contract the deadly disease Mesothelioma.
Supporters of the bill propose to set up a $140 billion dollar asbestos compensation fund, but it is doubtful if even an all out effort this week will bring the bill to a vote on the floor of the US Senate.
As Kennedy states victims suing the companies who exposed their loved ones to this disease did not create the costs. The costs, which include lost productivity, medical, care, along with payments to provide basic living needs for family members who died years before their time.
A shifting of financial burden to the victims and their families is, according to Kennedy unacceptable.
Kennedy recognizes the efforts by Senators Specter and Leahy who are in favor of passage of the bill. That said it has several fundamental flaws, which make it an unreasonable solution to the pending crisis.
Kennedy states our first obligation is to do no harm. Argument that there are certain inadequacies regarding how current asbestos litigation is handled should not be the major thrust toward passage of this bill.
Government intervention is the concern voiced across the nation by potential victims of this deadly disease. If the fund were to liquidate over time all potential damages would be in question. What rights would victims have in a legal setting to seek compensation from the offending companies?
Individuals concerned about their risks of legal passage of Bill S.852 can use the www.mesothelioma-attorney-case.com Legal Information page ( http://www.mesothelioma-attorney-case.com/legalissues.html ) to better understand the ramifications of the legal act. To gain more knowledge regarding the use of asbestos and the contraction of the disease see our research of Asbestos page ( http://www.mesothelioma-attorney-case.com/research.html ).
Internetbiz 2033 San Elijo Ave suite 254 Cardiff California 92007
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________ JR Roberts, a Security Expert Witness can help you prosecute or defend your criminal or negligent liability case in court. http://www.jrrobertssecurity.com/expert.html __________________________________________________ http://www.legal-search-engine.com http://www.vioxx-search-engine.com http://www.security-guard.org __________________________________________________
Asbestos Trust Fund Opposed By Mesothelioma Medical Experts
Mesothelioma Medical Experts Oppose Asbestos Trust Fund, Saying FAIR Act Hurts More than Helps
NEW YORK, Feb. 9 /PRNewswire/ -- The Doctor-Patient Alliance for Responsible Asbestos Policy today repeated its call on the U.S. Senate to cure fatal flaws in the proposed Asbestos Trust Fund bill (SB 852).
Last July, the nationwide group of 34 doctors who treat mesothelioma patients urged the U.S. Senate to remove the "one-size-fits-all" cap on awards and install a due process hearing, at which patients could prove their special medical and financial hardship damages and have their award tailored accordingly. The claims review system would be modeled after the 9/11 Victims Compensation Fund.
In addition, the Doctor-Patient Alliance asked for assurances that dying mesothelioma patients would be fairly compensated during their shortened life span. The detailed letter was sent to all 100 U.S. Senators.
"We are disappointed that our suggestions were ignored," said Dr. Harvey Pass, Chief of Thoracic Surgery at New York University Medical School. "This bill presented an historic opportunity to enact legitimate reforms that would directly benefit present and future meso patients. Regrettably, the bill actually hurts more than helps meso patients."
"The $1.1 million cap is insufficient to meet the medical, hospital, travel, lodging and other costs of mesothelioma patients who pursue the best treatments, which include surgery, chemotherapy, radiation, or a combination of therapies," said Dr. Robert Cameron, Chief of Thoracic Surgery at UCLA Medical School. "The inflexible cap fails to address the ongoing medical costs of patients who survive long enough to outlive the median survival time but who remain disabled and unable to earn a living. The bill ends up discriminating against the early stage, usually younger, patients whose life- long medical costs are certain to exceed their award.
"Mesothelioma must be treated as a chronic disease that requires a lifetime of care and treatment," said Dr. Cameron. "The costs of staying alive will far surpass the bill's arbitrary cap. Worse, some patients may decide against expensive novel treatments to stockpile the meager 'compensation' for their family."
In addition, the Alliance argues that any awards should be made while the money can be effectively invested in life-extending cures. "I doubt very much that the new bureaucracy will be up and running within my life time," predicts Dr. Bret Williams, age 52, a two year meso survivor who has incurred over $600,000 in medical bills. "It will take at least two years for the new federal agency to start paying out claims, while the median survival for mesothelioma patients is about nine months."
Dr. Williams, who has resolved his third-party civil claim, noted that most states have laws that allow in extremis meso patients to obtain preferential trial settings. For example, in Colorado and California, courts are required to set hardship meso cases for trial within 120 days. "I don't buy the rhetoric that an untested, under funded and at this point non-existent federal agency will pay out fair compensation faster than the court system," said Dr. Williams.
The Doctor-Patient Alliance has concerns that the bill will unduly restrict access to the Fund based on industry-friendly exposure criteria. "The Bill provides only for those with prolonged, occupational exposure. It excludes those with neighborhood exposure, or exposure only in schools or homes or while doing 'shade tree mechanic' work. It completely knocks out the first responders to the World Trade Center collapse," said Dr. Williams.
"My family would not have been compensated under the Trust Fund, since I was exposed while doing sporadic home repairs and while working with vermiculite potting soil," noted Dr. Williams.
"The U.S. Senate should correct these serious flaws or start over," said Dr. Pass. "Our government must do better when it comes to federal compensation initiatives. Recent studies of similar programs, like the Black Lung fund, make me skeptical that the asbestos trust fund will work. The motives may have been noble, but every federal compensation program to date has been marred by much higher costs, more claims than predicted, serious delays in meeting the demand and long intervals between the date the bill became law and the day the government started writing checks."
"I have a message for Dr. Frist," said Dr. Williams. "We belong to a privileged profession. Years ago, we dedicated ourselves to healing the sick, to caring for people from all occupations. It's been said that politics is 'medicine on a grand scale.' The principles guiding patient care should inform your decisions today. Let's ban asbestos. Let's fund research on effective treatments to stave off the asbestos health crisis. But let's not bail out industry at the expense of victims. Dr. Frist, do no harm."
For more information, see http://www.drpatientalliance.org/ . Contact: Dr. Harvey Pass Dr. Robert Cameron Chief of Thoracic Surgery Chief of Thoracic Surgery NYU School of Medicine UCLA Medical Center harvey.pass@med.nyu.edu rcameron@mednet.ucla.edu 212-263-7417 310-794-7333 Dr. Bret Williams, survivor Klaus Brauch, survivor Hillsborough, N.C. Huntington Beach, CA will118w@pol.net renaissance@learningteacher.com 919-732-4656 714-969-1481
Cure For Mesothelioma Aided By $1 Million of Research Funding
New Research Grants Continue Progress Against Dread Cancer
Mesothelioma Applied Research Foundation Announces Additional $1 Million of Research Funding
SANTA BARBARA, Calif., Feb. 23 /PRNewswire/ -- The Mesothelioma Applied Research Foundation ("MARF") announced today awards of almost $1 million in additional research funding aimed at curing mesothelioma ("meso"). An international and cross disciplinary set of nine new projects will go forward thanks to grants from MARF of $100,000 each. Researchers in Holland, Australia and the United States combined their efforts to field a broad spectrum of investigative efforts that are certain to advance the pace and scope of research success against this deadly cancer. Meso is a malignant tumor related to asbestos exposure that aggressively invades the mesothelial linings of the lungs, abdomen, heart, or testicles.
MARF's scientific experts selected the nine projects as the most important and promising among 28 high caliber applications received from around the world. For each of these two-year projects, the researchers are bound by strict budgeting and progress reporting requirements. Funds for the first year were paid in late 2005 and the research is now underway.
In a Phase I clinical trial focused on immune therapy, Doctor B.N.M. Lambrecht of the Erasmus Medical Center in Rotterdam, the Netherlands, plans to evaluate dendritic cells as a therapeutic adjuvant for treating malignant meso in humans. This grant follows up on previous successes with immunotherapy studies in mice that were very effective and also funded by MARF. Dendritic cells proved capable of generating an immune response when presenting meso tumor antigens and the current study intends to test the feasibility and safety of this approach.
Hot on the heels of meso-specific serum biomarker announcements in late 2004 and early 2005, researchers at USC under the direction of Dr. Ite Laird-Offringa were given a grant to continue investigating diagnostic markers for meso. USC plans to use DNA microarray chips to pre-screen 6500 serum markers using the MethyLight analytical system. Tissue samples would be examined to identify specific molecular markers found in meso tumor specimens with an eye to developing new serum tests to aid early diagnosis of the cancer.
The molecular understanding of the human genome has allowed researchers to undertake much more precise and tactical interventions against meso. Professor Xiaobo Cao of Texas A&M University, and his team, received a grant to investigate a specific gene family bcl-2, known to over-express a protein BCL-XL which blocks cell death (apoptosis) in mesothelioma tumors. Researchers wish to evaluate a bcl-2/bcl-xl antagonist, a compound that blocks the actions of the over-expressed protein, to see if it will cause tumor cell death and sensitize meso cells to the effects of existing chemotherapy agents. Such studies were virtually impossible ten years ago and represent the leading edge of scientific research today.
A Nevada Cancer Institute team under the direction of Dr. Sunil Sharma will continue its investigation of suberoylanilide hydroxamic acid (SAHA), a histone deacetylase (HDAC) inhibitor. SAHA and other HDLC inhibitors have demonstrated broad cancer activity and provide a promising new approach to therapy. Tumor resistance to HDAC inhibitors will be studied in an effort to identify combination therapies with mTOR inhibitors and nutrient uptake inhibitors that can increase tumor response to treatment. Dr. Sharma intends to generate a meso cell line resistant to SAHA and other drugs like valproic acid and then compare them to parent cell lines using molecular analysis to identify markers of resistance. These markers will then become targets for therapy.
MARF funded five other, equally innovative and important studies in this latest round of grants. Some of these research grants will become stepping stones; used to provide sufficient data to propose and win larger research grants from the National Institute of Health (NIH) and other government agencies. Using this approach, MARF-funded projects have had a multiplier effect on the total research investment into a cure for mesothelioma. Taken together, these studies have achieved, and will continue to achieve, results far in excess of what MARF could have accomplished alone. Without MARF's investment, however, little progress would have taken place.
For more information, contact MARF, the national nonprofit whose mission is to eradicate mesothelioma as a life-ending disease: http://www.marf.org; Executive Director Chris Hahn, 805-560-8942, c-hahn@marf.org; or Communications Director Klaus Brauch, 714-969-1481, k-brauch@marf.org.
SOURCE Mesothelioma Applied Research Foundation Web Site: http://www.marf.org
April 19, 2005 - AUSTRALIAN researchers have developed a world-first blood test which could help in the early detection of mesothelioma, a deadly asbestos-related cancer of the lung lining.
About 700 people every year are diagnosed with the disease in Australia, which has the highest reported incidence in the world.
It can take up to 30 years for symptoms of the condition to develop so most sufferers are identified at an advanced stage and die within a year.
The non-invasive blood test developed by University of Western Australia Professor Bruce Robinson and a team of researchers is a breakthrough in the early detection of mesothelioma.
Under existing arrangements, diagnosis is a long process which includes blood tests, chest x-rays, CT scans, drainage and laboratory analysis of the pleural fluid to help differentiate mesothelioma from other similar conditions.
The new blood test, named MESOMARK, was originally developed for cervical cancer at the Pacific Northwest Research Institute in the US, but Professor Robinson has adapted it for testing mesothelioma.
Dr Nick Pavlakis, a leading mesothelioma researcher in Sydney, said the blood test would be a valuable diagnostic aid for doctors.
"The test is a breakthrough because it's a simple blood test, it could therefore be applied to patients who are at risk, those who have a history of exposure or symptoms of the disease," he said.
The blood test measures the amount of protein in the blood, and a patient who returned a low reading would register a negative result.
But if the patient returned a high reading they would be sent for a second test to confirm the result.
Former painting contractor Erl Carlsson, who has mesothelioma, said the test would be valuable in monitoring the health of his family.
Mr Carlsson, 59, who lives in Narrabeen, on Sydney's northern beaches, was diagnosed with the disease in October last year after 30 years of sanding back asbestos fibro in his work as a painter.
He is now concerned for the health of his wife Barbara, who washed his clothes with asbestos dust on them, and children Andrew, 31, and Jenny, 32, who often worked with him when they were younger.
"It would really help the treatment, it's usually 20 or 30 years before you find out you have it ... it could have helped me too," Mr Carlsson said.
Dr Pavlakis said the amount of people diagnosed with the disease was expected to peak between 2010 and 2020 when the symptoms had fully developed.
"What we are seeing today is a product of exposure decades ago, so even though the legislation changed to reduce occupational exposure to asbestos fibres we have a decade lag time between the exposure and the disease," he said.
Symptoms for mesothelioma include breathlessness and chest pain.
Treatment, including chemotherapy, radiotherapy and surgery, aims to prolong life and keep the person as comfortable as possible.
Acupuncture without Needles Often Out-Performs Pain Relief Drugs
Pain Relief - New Acupuncture without Needles Technique Reports 80% Effectiveness, Often Out-Performing Drugs
Chronic pain, the most costly health problem in America today, often responds within minutes to EFT, a simple do-it-yourself acupressure technique.
San Francisco, CA (PRWEB) February 23, 2006 -- EFT, a new do-it-yourself pain relief procedure has shown remarkable benefits in thousands of clinical applications. Its potential use worldwide may produce major economic breakthroughs in pain management.
For example, chronic pain costs the United States an estimated $50 billion every year, making it the countrys most expensive health problem. An estimated 7 million are partially or completely disabled by back pain, and most adults experience occasional back problems. Arthritis affects 40 million and costs over $4 billion in lost income and health care. Another 45 million suffer chronic, recurrent headaches and spend $4 billion per year on medication.
Prescription drugs provide some relief, but they dont always work, their side effects can be serious, and the pain usually returns.
One promising treatment recognized by the National Institutes of Health is acupuncture, the ancient Oriental practice of inserting needles at key points along energy meridians. Acupuncture works by removing blocks along these meridians, allowing energy to flow freely, relieving pain and other symptoms in the process.
Now a do-it-yourself procedure takes acupuncture to a new level by addressing unresolved emotional issues that contribute to pain. Emotional Freedom Techniques, or EFT, combines gentle fingertip tapping on key acupuncture points with focused thought, effectively reducing and often permanently eliminating chronic pain. According to Its practitioners, EFT is more than 80-percent effective in treating headaches, back pain, cancer pain, arthritis, and pain from other conditions.
Steve Wells, an Australian EFT practitioner, worked with a Vietnam War veteran whose chronic lower back pain disappeared in less than a minute. He spent the remainder of the session trying to bring his pain back, says Wells, but it didnt return. Wells reports similar results for clients with shoulder pain, migraine headaches, knee pain, and other conditions.
According to Stephanie Rothman, CHT, My clients have experienced relief from pain and discomfort from headaches, neck stiffness, PMS, allergies, asthma, fibromyalgia, hiccups, stomach cramps, hangovers, and post-surgical discomfort, using only EFT.
Los Angeles physician Eric Robins, MD, finds that EFT often works when conventional therapies fail. Again and again, he says, patients with chronic pain have unresolved emotional issues or anger thats tied to past traumas. Stress and negative emotions arent just in our heads, they are stored in our bodies, often in skeletal or smooth muscles. Its hard for blood to flow through chronically tensed muscles.
This model, he explains, agrees with the theories of John Sarno, MD, Professor of Rehabilitation Medicine at New York University in New York City and author of the best-selling Healing Back Pain: The Mind-Body Connection and other books. Dr. Sarno treats patients not with drugs or surgery but with anger management.
He sees some of the worse chronic pain patients in the world, says Dr. Robins. Most have been in pain for 10 to 30 years despite surgeries, epidural injections, and years of physical therapy. He teaches them that the cause of their pain is anger and that when they let go of the anger, their pain will disappear. He consistently produces a cure rate thats close to 70 percent in terms of pain and function, and an additional 15 percent are much improved.
Dr. Robins considers EFT the most effective, fastest-acting anger management technique available. Like most doctors, Im always in a hurry, he says. If I can teach EFT to a patient in just a few minutes and completely resolve not only chronic symptoms but their underlying cause, thats terrific. In fact, its phenomenal. Nothing in the pharmaceutical world comes close.
Although most Americans have yet to hear of it, EFT may be the worlds fastest-growing self-help technique. Between 5,000 and 10,000 worldwide including hundreds of health care practitioners download the EFT websites free instruction manual each week, and 175,000 subscribe to its online newsletter.
The EFT website generously offers a EFT Free Get Started Package to the public. It includes the EFT Manual (contains all the basics so you can apply it right away) and a free subscription to its popular online newsletter. It can be freely downloaded at
State of HIV/AIDS in Indiana; Medical Costs Under New Medicare/Medicaid
Coalition to Address the State of HIV/AIDS in Indiana; Calls for HIV Gap Fund to Address Medical Costs Under New Medicare/Medicaid
The Indiana Minority Health Coalition (IMHC), the states leading minority health research and community care agency, today launches its 2006 Indiana Minority Health Call to Action focusing on HIV/AIDS. The agency will offer several advocacy activities and rally statewide support of a new fund, The HIV Gap Fund, to offset increased changes in state and federal support.
Indianapolis, IN (PRWEB) February 22, 2006--The Indiana Minority Health Coalition (IMHC), the states leading minority health research and community care agency, today launches its 2006 Indiana Minority Health Call to Action focusing on HIV/AIDS. The agency will offer several advocacy activities and rally statewide support of a new fund, The HIV Gap Fund, to offset increased changes in state and federal support.
The theme of this years initiative is Think Global Act Local: a focus on HIV/AIDS. IMHC, along with a planning group comprised of People Living with HIV and AIDS, public health leaders, elected officials, and faith, community and business leaders, will engage in advocacy and action days around the state culminating with a march from Monument Circle in Indianapolis to the Indiana State House on April 19, from 1 -3 p.m.; and the 12th annual initiative luncheon featuring an international celebrity, humanitarian and HIV/AIDS spokesperson on April 20 at The Westin Hotel, in downtown Indianapolis, from 11 am 2 pm.
Since 1981 when the first cases were diagnosed, AIDS has killedmore than 20 million people, in the minorities/ethnic communities, accounting for 40 percent of those deaths. In addition, in the United States racial/ethnic minorities account for more than 40 percent of the estimated 944,306 AIDS cases that have been diagnosed, making up 12.2 percent of the population.
To address this health concern, IMHC will work with community members to encourage them to take action within their counties. The organization is partnering with the 12 regions for the initiative, based on care coordination sites defined by the Indiana State Department of Health. Volunteers and participants in each region will receive HIV/AIDS Issues and Action Toolkits that will include current Indiana HIV/AIDS data and talking points that affect those infected and impacted; guide communities on developing their own local events; and develop methods to engaged elected officials such as the HIV/AIDS education day.
HIV/AIDS education is the priority for the initiative with the key message of getting support for the HIV Gap Fund to help save Hoosier lives. The fund is critical to Indiana residents who lack financial and social support resources. People living with HIV/AIDS and other life altering diseases are in a difficult position because they can not absorb the high cost of medications. Some HIV/AIDS medications alone range from $800-$1,250 per person per month.
The HIV Gap Fund will provide individuals with resource to help obtain their medication if they are faced with shortfalls in insurance, co-pays, spend downs or lack of social services.
IMHC is dedicated to closing the gap in health care in our communities. We are rallying to save the lives of our loved ones, neighbors and co-workers. The HIV/AIDS education and advocacy activities from now through April are just our way of bringing awareness about this health epidemic and the action needed to prolong life right here in Indiana, said IMHC CEO and President Nancy Jewell.
For more information on how to participate in IMHCs Call to Action: HIV/AIDS Lobby Days, call 1-877-367-4642
About IMHC: The Indiana Minority Health Coalition is a statewide non-profit organization formed by a grassroots movement in 1992 to ensure that no racial or ethnic minority child, adolescent, or adult suffers more from a preventable adverse health condition than non-minorities. IMHC has 16 local coalition affiliates servicing 29 counties throughout the state that provide a myriad of health programs and services to the community with the goal of eliminating health disparities.
# # #
Press Contact: Tysha Hardy-sellers Company Name: INFINITE INC. Email: email protected from spam bots Phone: 317 955-9456 +103 Website: www.imhc.org
New Infection Control Procedure for Hospital Transport Systems
Swisslog Healthcare Division Announces Release of New Infection Control Procedure for Hospital Transport Systems
This guideline procedure addresses potential system spills using pneumatic tube systems in hospitals. Infection control clean up procedures are presented as well as packaging guidelines - and the latest federal regulatory agency citations such as OSHA, the CDC and CLSI.
Denver, Colorado (PRWEB) February 22, 2006 -- Swisslog Healthcare Solutions Division announces the release of its new Infection Control Procedure for the Transport of Specimens in a Swisslog Pneumatic Tube System.
The 8-page document outlines specimen transport and handling issues relating to potential spills associated with automated material transport in hospitals. Included are guidelines for container testing, and secure packaging of specimens
The report focuses on pneumatic tube system use and addresses system spill procedure, decontamination and disinfectant situations. Swisslog has monitored reports provided by safety regulation agencies including the Center for Disease Control (CDC), the Occupational Safety and Health Administration (OSHA) and the Clinical Laboratory Standards Institute (CLSI) and has incorporated pertinent references to agency reports and guidelines.
Swisslog provides a comprehensive hospital training program for its pneumatic tube system users entitled Template for Pneumatic Tube System Protocol which has become a standard in many North American hospital institutions. The Infection Control Procedure is presented as an integral component in that protocol program.
The new Infection Control document new incorporates agency contact information, web resources, and references to pertinent infection control publications, agencies and more.
Hospital staffs can learn more about Swisslogs Infection Control Procedure by visiting the Swisslog Healthcare Solutions Patient Protection web page at:
Hospital staffs may contact Swisslogs Customer Solutions Group and requesting either an electronic or printed edition of the new procedure (1-800-764-0300).
About Swisslog Swisslog is a global provider of integrated logistic solutions for warehouses, distribution centers and hospitals. The comprehensive portfolio ranges from building complex warehouses and distribution centers including Swisslogs software, in-house logistics solutions for hospitals as well as software and consulting services in the field of supply chain management. Swisslogs solutions optimize the customers production, logistics and distribution processes in order to increase their flexibility, responsiveness and quality of service, while minimizing logistics costs.
With years of experience in the development and implementation of integrated logistics solutions, Swisslog provides the expertise that customers in more than 50 countries around the world rely on. Headquartered in Buchs/Aarau, Switzerland, Swisslog currently employs around 1,850 staff in 23 countries worldwide. For more information, go to www.swisslog.com and visit the Swisslog Healthcare Solutions Division.
###
Press Contact: Craig Swank Company Name: SWISSLOG Email: email protected from spam bots Phone: 303-373-7923 Website: www.swisslog.com
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________ JR Roberts, a Security Expert Witness can help you prosecute or defend your criminal or negligent liability case in court. http://www.jrrobertssecurity.com/expert.html _______________________________________________________
Food Can Treat Many Illnesses As Effectively As Drugs
Science Reveals That Food Can Treat Many Illnesses As Effectively As Drugs
Press Release by: Innovative Healing
Published on openPR 02-20-2006 11:04 am - CET
(openPR) - February 20, 2006 -- Naturopathic doctor, Michael Murray will appear Wednesday, March 15, 2006 as a special guest as a guest on Dr. Liz Lipskis Access to Health Experts interview series to discuss his new book, The Encyclopedia of Healing Foods. Dr. Murray will discuss his work showing that diet plays a major role in both provoking and preventing a wide range of diseases. The presentation will have a special focus on the medicinal properties of food.
During the free one-hour teleseminar Dr. Murray will cover the following topics: using foods to stimulate the bodys natural ability to rejuvenate and heal discovering the role of fiber, enzymes, fatty acids, and other dietary components understanding which food prescriptions will help you safely treat more than 70 specific ailments, including acne, Alzheimers disease, immune system depression, insomnia, migraine headaches, PMS, and rheumatoid arthritis preparing foods safely in order to prevent illness and maximize health benefits
Grounded in rigorous scientific research, the Dr. Michael Murrays interview is expected to offer health-conscious eaters scores of valuable food facts. Dr. Murray is known for his ability to make learning about nutrition fascinating, with historical tidbits and discoveries from the laboratory. And he makes practicing it easy and enjoyable, with tips on selecting, storing, and preparing all kinds of healthful foods, plus quick, inventive, and delicious recipes.
To attend the free Access to Health Experts interviews visit http://innovativehealing.com. Written and audio transcripts are available for purchase after the event from the Innovative Healing Book Store.
About Dr. Murray: Michael T. Murray, N.D. is widely regarded as one of the world's leading authorities on natural medicine. He is a graduate, faculty member, and serves on the Board of Trustees of Bastyr University in Seattle, Washington. Dr. Murray is the co-author of A Textbook of Natural Medicine, the definitive textbook on naturopathic medicine for physicians, as well as the consumer version Encyclopedia of Natural Medicine. He has also written over 20 other books.
About Access to Health Experts: Access to Health Experts is a monthly teleseminar interview series hosted by Liz Lipski, PhD, CCN. The program features interviews with many of the most prominent and authoritative experts in integrative medicine. Dr. Lipski is a nationally-known nutritionist and author of Digestive Wellness (3rd Edition McGraw Hill). Innovative Healing is located in Asheville, North Carolina. For more information visit http://innovativehealing.com.
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________ JR Roberts, a Security Expert Witness can help you prosecute or defend your criminal or negligent liability case in court. http://www.jrrobertssecurity.com/expert.html __________________________________________________ http://www.legal-search-engine.com http://www.vioxx-search-engine.com __________________________________________________
Significance of Mutations in the Avian Influenza Viruses
Avian Influenza: Significance of Mutations in the H5N1 Virus
GENEVA, Feb. 21 /Xinhua-PRNewswire/ -- Several recent media reports have included speculations about the significance of mutations in H5N1 avian influenza viruses. Some reports have suggested that the likelihood of another pandemic may have increased as a result of changes in the virus.
Since 1997, when the first human infections with the H5N1 avian influenza virus were documented, the virus has undergone a number of changes.
These changes have affected patterns of virus transmission and spread among domestic and wild birds. They have not, however, had any discernible impact on the disease in humans, including its modes of transmission. Human infections remain a rare event. The virus does not spread easily from birds to humans or readily from person to person.
Influenza viruses are inherently unstable. As these viruses lack a genetic proof-reading mechanism, small errors that occur when the virus copies itself go undetected and uncorrected. Specific mutations and evolution in influenza viruses cannot be predicted, making it difficult if not impossible to know if or when a virus such as H5N1 might acquire the properties needed to spread easily and sustainably among humans. This difficulty is increased by the present lack of understanding concerning which specific mutations would lead to increased transmissibility of the virus among humans.
Animal viruses
Virtually all the known subtypes of influenza A viruses circulate in some wild birds, most notably wild waterfowl. In these birds, different viruses constantly mingle with each other and frequently exchange genetic material, resulting in a huge pool of constantly changing viruses. Mutations and reassortment events are commonly observed in the affected bird populations.
In animals, some recent evolutionary changes in the H5N1 virus appear to have made control efforts more difficult and further international spread of the virus in birds more likely. Such changes are fully understandable, particularly in view of the exceptionally large number of birds that have been infected with the H5N1 virus and the frequent interactions between infected free-ranging poultry and wild waterfowl.
Studies have shown that H5N1 viruses from the current outbreaks, when compared with viruses from 1997 and 2003, have become progressively more lethal in experimentally infected chickens and mice, and are also hardier, surviving several days longer in the environment. Other studies have shown that the virus is not yet fully adapted to poultry and is continuing to evolve.
Domestic ducks have acquired an ability to resist the disease caused by some strains, and are now capable of excreting large quantities of highly pathogenic virus without showing the warning signs of illness. In endemic countries, this altered role of domestic ducks is now thought to contribute to perpetuation of the transmission cycle. Research conducted in South-east Asia has recently shown that multiple distinct lineages of H5N1 virus have become established in poultry in different geographical regions, indicating the long- term endemicity of the virus in parts of Asia. That research also detected highly pathogenic H5N1 virus in apparently healthy migratory birds.
In birds, one important recent finding has been the remarkable similarity of viruses from recent outbreaks to those isolated from migratory birds that began dying at the Qinghai Lake nature reserve in central China in late April 2005. Evidence is mounting that this event, which resulted in the deaths of more than 6,000 wild birds, signalled an important change in the way the virus interacts with its natural reservoir host.
Unlike the case with mutations of human viruses (some of which have been transient), it appears that some changes have become fixed in viruses circulating in at least some species of wild birds.
Prior to the Qinghai Lake event, the highly pathogenic H5N1 virus was known to cause occasional sporadic deaths in migratory waterfowl, but not to kill them in large numbers or be carried by them over long distances.
Viruses from Qinghai Lake showed a distinctive mutation at one site experimentally associated with greater lethality in birds and mice. Viruses from the most recent outbreaks, in Nigeria, Iraq, and Turkey, as well as from earlier outbreaks in Russia, Kazakhstan, and Mongolia, are virtually identical to Qinghai Lake viruses.
It is considered unusual for an avian influenza virus causing outbreaks in birds to remain this genetically stable over so many months. This finding raises the possibility that the virus -- in its highly pathogenic form -- has now adapted to at least some species of migratory waterfowl and is co-existing with these birds in evolutionary equilibrium, causing no apparent harm, and travelling with these birds along their migratory routes.
If further research verifies this hypothesis, re-introduction of the virus or spread to new geographical areas can be anticipated when migratory birds begin returning to their breeding areas.
The recent appearance of the virus in birds in a rapidly growing number of countries is of public health concern, as it expands opportunities for human exposures and infections to occur. These opportunities increase when the virus spreads from wild to domestic birds, especially when these birds are kept as backyard flocks in close proximity to humans.
To date, no human cases have been linked to exposure to wild birds. Close contact with infected poultry and other domestic birds remains the most important source of human infections.
Human viruses
Some mutations have been detected in human viruses isolated in 2005 and, most recently, in one virus isolated from a fatal case in the January 2006 outbreak in Turkey. Although these mutations were found at the receptor- binding site and involved the substitution of more mammalian-like amino acids, the effect of these changes on transmissibility of the virus, either from birds to humans or from one person to another, is not fully understood. Moreover, recent studies show that these mutations were transient and did not become fixed in the circulating viruses.
Scientists do not presently know which specific mutations are needed to make the H5N1 virus easily and sustainably transmissible among humans. For example, it is not known whether the absence of a specific receptor in humans for this purely avian virus is responsible for the present lack of efficient human-to-human transmission. For this reason, virological evidence of mutational changes must be assessed together with epidemiological information about transmission patterns actually occurring in human populations. This necessity further underscores the importance of close surveillance and thorough investigation during every outbreak involving human cases.
Assessments of the outbreak in Turkey, conducted by WHO investigative teams, have produced no convincing evidence that mutations have altered the epidemiology of the disease in humans, which was similar to the pattern consistently seen in affected parts of Asia. There is no evidence, at present, from any outbreak site that the virus has increased its ability to spread easily from one person to another.
WHO reports only laboratory-confirmed cases. http://www.who.int/csr/disease/avian_influenza/country/ cases_table_2006_02_20/ en/print.html
For more information, please contact:
Aphaluck Bhatiasevi Communications Officer World Health Organization (China) Mobile: +86-1361-117-4072 Tel: +86-10-6532-5687 Fax: +86-10-6532-2359 Email: bhatiasevia@chn.wpro.who.int
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040610/CNTH001LOGO AP Archive: http://photoarchive.ap.org/ PRN Photo Desk, +1-888-776-6555 or +1-212-782-2840
Source: World Health Organization
CONTACT: Aphaluck Bhatiasevi of World Health Organization (China), +86-1361-117-4072 or +86-10-6532-5687, or fax, +86-10-6532-2359, or bhatiasevia@chn.wpro.who.int
Web Site provides Information On Asbestos Litigation Headed to the Senate
Bill S.852 - the Fairness in Asbestos Injury Resolution Act of 2005 is facing several obstacles in Capitol Hill this coming week.
(I-Newswire) - Bill S.852 - the Fairness in Asbestos Injury Resolution Act of 2005 is being positioned by lobbyists as the answer to the legal quagmire regarding Mesothelioma litigation. Limited exposure to airborne asbestos fibers can lead to contraction of Mesothelioma.
Supporters of the bill propose to set up a $140 billion dollar asbestos compensation fund, but it is doubtful if even an all out effort this week will bring the bill to a vote on the floor of the US Senate.
Government intervention is the concern voiced across the nation by potential victims of this deadly disease. If the fund were to liquidate over time all potential damages would be in question. What rights would victims have in a legal setting to seek compensation from the offending companies?
That said, mesothelioma-attorney-case.com identifies with those opposed to the passage of Bill S.852 - the Fairness in Asbestos Injury Resolution Act of 2005.
Individuals concerned about their risks of legal passage of Bill S.852 can use the www.mesothelioma-attorney-case.com legal Information page ( http://www.mesothelioma-attorney-case.com/legalissues.html ) to better understand the ramifications of the legal act. To gain more knowledge regarding the use of asbestos and the contraction of the disease see our research of Asbestos page ( http://www.mesothelioma-attorney-case.com/research.html ). On this page mesothelioma-attorney-case.com explains the symptom. Diagnosis along with epidemiology issues regarding contracting Mesothelioma.
In addition, mesothelioma-attorney-case.com explains the treatment options available to those who have contracted the disease, as well as how friends and family can help support the fight against Mesothelioma.
Internetbiz 2033 San Elijo Ave suite 254 Cardiff California 92007
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________ http://www.legal-search-engine.com http://www.vioxx-search-engine.com __________________________________________________
Mesothelioma Outcome Improved With Early Chemotherapy
Early Chemotherapy Improves Outcomes for Mesothelioma
According to a recent article published in the Annals of Oncology, immediate treatment with chemotherapy improves survival rates at one year and provides improved quality of life compared to administering chemotherapy once symptoms occur in patients with malignant mesothelioma.
Malignant pleural mesothelioma is a rare cancer that develops in the tissue that covers the lungs and lines the interior of the chest. The majority of individuals who develop malignant pleural mesothelioma have a history of chronic exposure to asbestos.
The only curative treatment for mesothelioma is surgery. However, more than 70% of patients diagnosed with mesothelioma have advanced disease, which places them beyond the curative benefits of surgery. These patients are treated with chemotherapy following surgery with the main goal of treatment being to extend survival time and improve quality of life.
Researchers from England recently conducted a clinical trial to evaluate different timing of the administration of chemotherapy in patients with malignant mesothelioma. This trial included 43 patients who had undergone surgery and had stable disease symptoms for at least 4 weeks. Approximately half of the patients then received immediate chemotherapy consisting of the regimen referred to as MVP (mitomycin, vinblastine, cisplatin, or carboplatin), while the other half did not receive MVP until disease symptoms occurred.
Overall, patients treated with early chemotherapy had improved outcomes:
Median survival was 14 months for patients treated with immediate chemotherapy, compared with 10 months for those treated with delayed chemotherapy.
At one year, survival rates were 66% for those treated with immediate chemotherapy, compared with 36% for those treated with delayed chemotherapy.
Quality of life was generally better among patients treated with early chemotherapy.
Health resource utilization was comparable between the two groups of patients.
The researchers concluded that chemotherapy prior to the onset of disease symptoms improves outcomes compared to administering chemotherapy once symptoms have occurred in patients with mesothelioma. Patients with mesothelioma may wish to speak with their physician regarding their individual risks and benefits of chemotherapy timing.
Reference: OBrien M, Watkins D, Ryan C, et al. A Randomised Trial in Malignant Mesothelioma (M) of Early (E) Versus Delayed (D) Chemotherapy in Symptomatically Stable Patients: the MED Trial. Annals of Oncology. 2006;17:270-275.
A fragrance-free Organic lotion for sensitive skin is quickly becoming the product of choice for many cancer patients suffering side effects from chemotherapy.
(PRWEB) February 16, 2006 -- A fragrance-free Organic lotion for sensitive skin is quickly becoming the product of choice for many cancer patients suffering side effects from chemotherapy.
Recently, when cancer patient Kristina Jones was searching for a lotion to soothe the burning, itching sensation in her face and upper body (a common side effect of chemotherapy), she turned to her neighbor and friend Kim Cabot, owner of BONICCA Natural Body Care. Kim gave her some Unscented Bonicca Organic Spa Lotion, knowing that the high organic aloe content and all natural ingredients would be gentle to Kristinas irritated skin. The itching and burning were relieved immediately, reported Jones, and the chapping, redness and swelling subsided in just a few hours. I feel like a new person!
Bonicca President Kim Cabot states, We are working hard to create the highest quality organic products and we are offering samples of this remarkable product to Cancer clinics across the country. More information is available at www.bonicca.com
WHY ORGANIC: When products are applied directly to the body, up to 60% of the compounds in the product are absorbed into the skin, including any toxic ingredients. This is the primary concern with toxic cosmetic ingredients. Lotions, creams and oils affect the skins appearance precisely because they are being absorbed. While looking your best is the reason many people use cosmetics, the ill effects of toxic ingredients is alarming, and is of even greater concern for people whose immunities are weakened by illness or medication.
CHOOSE ORGANIC PRODUCTS CAREFULLY: According to a 2006 Consumer Report about buying organic cosmetic products, many body lotions and shampoos that carry the organic label use an indiscriminate amount of synthetic ingredients. Many ingredients in personal care products didnt grow out of the ground but in test tubes theyre chemicals, says Lauren Sucher, director of public affairs at the EWG (Environmental Work Group (www.ewg.org). Just because a product has the word organic or natural in its name doesnt necessary mean its safer.
A few of the potentially toxic chemicals found in personal care products are:
Phthalates: An industrial chemical very commonly found in consumer cosmetics. Linked to lung, liver and kidney damage and birth defects in the male reproductive system. A recent study by the EWG tested 72 name brand, off the shelf beauty products for the presence of phthalates. The lab found phthalates in 52 of the 72 products tested (72%) although only one listed phthalates on the label.
Parabens: The most commonly used preservatives in consumer cosmetics. Parabens (usually listed by one of their compound names, such as methylparaben, propylparaben, etc.) readily penetrate the skin and, according to the Womens Environmental Network (WEN), research indicates that they can act as estrogen mimics, disrupting normal biological and reproductive functions. Numerous studies have also linked parabens to breast cancer, prompting the Campaign for Safe Cosmetics (www.safecosmetics.org) to request that cosmetic manufacturers voluntarily discontinue the use of these preservatives.
Ultrafine Particles (UFPs): Found in a number of newer cosmetics, including some sunscreen preparations which incorporate nanoparticle titanium dioxide. These UFPs have demonstrated toxicity and according to Dr. Vyvyan Howard, a toxicologist at Liverpool University, can enter the lymphatic system via the skin.
MORE ABOUT BONICCA Skin Care Products:
Bonicca currently offers three signature products (Lotion, Shower Gel, and Bath Salts) in nine fragrances as well as unscented / fragrance-free. The Lotion and Shower Gel both contain slightly over 70% organic ingredients, with the remainder of the base ingredients made up of all natural and non toxic ingredients. The Bath Salts are also all natural. In keeping with the highest standards for the industry, Bonicca does not count water or water-based ingredients when calculating the organic percentage. The base for all of their lotions and gels is certified organic aloe vera juice (rather than the traditional water or flower water), which makes for a richer and more penetrative and effective product. All products are paraben and sulfate free. Bonicca products are certified animal cruelty free by the Coalition for Consumer Information in Cosmetics, and the company is a member of the Organic Trade Association. Bonicca is also one of fewer than 200 companies nationwide to sign the Breast Cancer Funds Compact for Safe Cosmetics committing to the highest standards of product safety and purity.
Media Contact: Melinda Manos 818-865-1058 Please contact us for more information, free samples or to interview Kimberly Cabot.
###
Press Contact: Melinda Manos Company Name: MANOS MANAGEMENT & PUBLIC RELATIONS Email: email protected from spam bots Phone: 818-865-1058 Website: www.bonicca.com
_______________________________________________________ Free magazinesubscriptions are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________ JR Roberts, a Security Expert Witness can help you prosecute or defend your criminal or negligent liability case in court. http://www.jrrobertssecurity.com/expert.html _______________________________________________________
Get More Patient Referrals With Electronic Medical Records
Electronic Medical Records Increase Patient Referrals in Small Practices
Most people become doctors because they want to help people live healthier lives. They start their own practice, begin seeing patients and worry about developing a strong client base. Helping people comes easy to them. However, building a business, differentiating themselves from other practices in the area and developing a consistent flow of referrals is often a hard job.
Redondo Beach, CA (PRWeb) February 16, 2005 -- 2K Electronic Medical Records, located in Redondo Beach, California says many small practices see an increase in patient referrals after implementing Electronic Medical Records.
Most people become doctors because they want to help people live healthier lives. They start their own practice, begin seeing patients and worry about developing a strong client base. Helping people comes easy to them. However, building a business, differentiating themselves from other practices in the area and developing a consistent flow of referrals is often a hard job.
Every physician knows how important referrals are for their practice to grow. They somehow need to brand themselves as different from their competition, explains Tammy Harrison, owner of 2K Electronic Medical Records. Putting systems in place to create a better, safer patient experience will do just that.
According to Harrison, there are many inexpensive, customizable software packages specifically made for small practices. After implementing practice management systems many practices have seen an immediate improvement in referrals. Practices report receiving referrals from pharmacists, other patients, and even other doctors in the community.
Dr. Carolyn Vogler with Dermott Family Practice in Arkansas says, All the pharmacists around here love me. The pharmacies dont have to decipher anything. I get referrals from them all the time.
Harrisons company specializes in helping medical practices put these systems in place. There are many alternatives for the smaller practice that are not cost-prohibitive, Harrison tells us. The key is finding the right package for your individual needs.
For more information about the systems that will help physicians increase referrals and improve their patients experience, visit www.2Kmedicalrecords.com
CONTACT: Tammy Harrison, President of 2K Electronic Medical Records 310-937-8924
###
Press Contact: Tammy Harrison Company Name: 2K Electronic Medical Records Email: Tammy@2KMedical Billing.net Phone: 310-937-8924 Website: www.2KMedicalrecords.com
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________ JR Roberts, a Security Expert Witness can help you prosecute or defend your criminal or negligent liability case in court. http://www.jrrobertssecurity.com/expert.html _______________________________________________________
FDA Seizures of Canadian Drugs Unnecessarily Endangering U.S. Patients
Recent interdictions of Canadian drug packages by U.S. Customs agents are part of a calculated campaign to intimidate patients who order life-saving medications from licensed online Canadian Pharmacies. Interruptions in established medical therapy are putting patients at unnecessary risk.
Calgary, Canada (PRWEB) February 13, 2006 -- The U.S. FDA has been ramping-up interdictions of Canadian drug packages in what appears to be an intentional intimidation campaign timed to coincide with the launch of the controversial Medicare Part D prescription drug program. Seizure rates at major border entry points have increased nearly ten-fold since December and are accompanied by a letter that obviously intends to frighten patients. Licensed and legitimate online Canadian pharmacies like Minit Drugs (www.pharmacy-online.ca) are reporting hundreds of seizures in the last 2 months, up substantially from previous averages.
We have historically been prepared to absorb the cost of re-shipping seized medications as a necessary business expense. But now, the FDA is on a rampage to snuff-out even legitimate online pharmacies because they pose an obvious threat to the struggling Medicare drug program, says Barney Britton, CEO of Minit Drugs (www.pharmacy-online.ca). Clearly the FDA is acting on a political agenda.
Evidence that recent seizures are part of a deliberate operation is substantiated by Mark Conrad, a retired U.S. Customs special agent, after he was contacted by an anonymous whistleblower in Miami alerting him than an intentional seizure program was underway. Officials from Customs and Border Protections public affairs office in South Florida did not return a phone call seeking comment on the operation.
The Canadian International Pharmacy Association (CIPA), a trade group in which Minit Drugs is a member in-good-standing, fears that U.S. patients could be unduly harmed as a result of the FDAs political tactics. "It's an issue of patient safety," says Andy Troszok, CIPA President. "We're not talking about Viagra and narcotics abuse. We are talking about people with breast cancer, heart disease and diabetes on established medication. Who is going to be liable for these people going off medical regimens and suffering or even dying?"
As a safe and reputable pharmacy in Canada that sustains thousands of U.S. patients on prescribed therapies, Minit Drugs calls on the FDA and Customs officials to verify Canadian licensure as a means of differentiating credible online pharmacies from potentially illegitimate ones. If protecting the health of U.S. citizens is a priority then they should reconsider their actions. If your enforcement is doing more harm than good, its time to look at your policies, adds Britton.
Minit Drugs is a licensed pharmacy located in Calgary, Alberta (AB License # 1657), is CIPA certified and IMPAC accredited. All Canadian drugs are approved by Health Canada and dispensed by licensed pharmacists.
Children and Cancer Survivor to Lead Teams In Nationwide Climbing Event to Fight Cancer
The Climb For Cancer Foundation announces two children and a cancer survivor have volunteered to be team leaders for their first annual nationwide mountain climbing event to fight cancer. The event, known as 50-50-1 will include climbing teams in all 50 states in the US, scaling the highest peak in each state on the same day. 50-50-1 stands for 50 states, 50 peaks, one goal.
Gainesville, FL (PRWEB) February 13, 2006 -- The Climb For Cancer Foundation announces two children and a cancer survivor have volunteered to be team leaders for their first annual nationwide mountain climbing event to fight cancer.
Charlie Marr, 12, and Isabelle Richmond, 13, have signed on to lead teams in Maine and Illinois respectively, to climb the highest peak in their home states. Cancer survivor, Bob Mayer will be leading the Maryland climbing squad, as several other survivors of the disease have signed up as team members in various states.
The event, known as 50-50-1 will include climbing teams in all 50 states in the US, scaling the highest peak in each state on the same day. Each team will raise $5,000, which will in turn help to fund important research to find a cure for cancer, provide patient support services, and give a child with cancer the opportunity to attend Camp Sunshine. 50-50-1 stands for 50 states, 50 peaks, one goal.
It will give a chance to kids with cancer to go to camp, play sports and have fun just like I do, says Marr of 50-50-1. I hope someday that all kids with cancer are healthy enough to climb the highest peak in their state. Most importantly, I want kids with cancer to know everyone cares about people with the disease and this foundation shows that.
Isabelle Richmond added, "I would like to do something for children with cancer. My Grandmother died of cancer, so I would like to help raise money for cancer research."
The Climb For Cancer Foundation was started by Ron and Dianne Farb to combine Ron's love for mountain climbing with their desire to see an end to cancer. The Foundation acquires sponsors and donations in support of Ron's mountain climbing expeditions, and then uses the money raised to help fund cancer research and support services. Ron has climbed five of the seven summits, the highest peaks on each continent, raising more than $300,000. For more information on the Climb For Cancer Foundation, go to www.cfc-foundation.org.
For more information on this event, visit www.50-50-1.com or contact Ron Farb at email protected from spam bots or 352-333-9663.
###
Press Contact: Ron Farb Company Name: Climb For Cancer Foundation Email: email protected from spam bots Phone: 352-333-9663 Website: http://www.50-50-1.com
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________ JR Roberts, a Security Expert Witness can help you prosecute or defend your criminal or negligent liability case in court. http://www.jrrobertssecurity.com/expert.html _______________________________________________________
Free Prescription Medicines and Free Diabetes Testing Supplies
Company Assists Low Income and Seniors with Free Prescription Medicines and Free Diabetes Testing Supplies
Nova Group of Memphis, Inc. adds Free Diabetes Testing Supplies and launches national Free Prescription Drug program for low income individuals, families and seniors. Free delivery.
Memphis, TN (PRWEB) February 10, 2006 -- Nova Group of Memphis, Inc. is now assisting low income families via internet and personal phone calls for applying and receiving Free Prescription Medicines and Free Diabetes Testing Supplies including test strips. Most of their clients have been outside of Tennessee until recently when the Tenncare disenrollment letters started arriving. Income requirements are two times the 2005 poverty level-$19,000 for a single person household and $25,660 for two person household. One company accepts a two person household for as high as $31,000. There are other higher ranges for families who have dependant children.
Boston explains the process: Not only do we assist them to find free or discounted medication, we give them free information on any other assistance we can find during our research. Our savings on diabetes testing supplies is also being well received. Prescription Medications and testing supplies are provided on a quarterly basis unless otherwise limited by the physician or drug manufacturer.
Typically a client fills out an online questionnaire with a list of prescriptions, income information and expenses for medical care and basic needs such as rent/mortgage payments and utilities. In conjunction with Nashville based Benefits Advocate, we research several databases to find programs they are qualified for and then discuss a plan to help improve their situation. And there is no obligation to apply-research is free.
The cost is extremely low compared to the savings with the program. There is a $20.00 set up charge and $15.00 per month for on-going support, service and administration. People can easily save $200-$500 per month if they qualify. Every application requires a doctors signature and license number, proof of income and a three month prescription. The application is then mailed to each program administrator for review and the meds are shipped to doctors for dispensing or directly to the patient.
We are committed to helping as many clients as possible Boston continues. It is really rewarding when we hear the relief in a persons voice that their prescriptions can be obtained and they will not be without medication. Weve made a lot of new friends in the process.
The Free Prescription Medicine and Free Diabetes Testing Supply programs are national in scope for low income and non-insurance covered individuals and families. Nova is also approved with Medicare, TennCare and Medicaid.
Nova also works closely with clinics, physician offices, hospital groups, non-profit and religious organizations providing assistance and out reach programs to lower income individuals and families. Employers who have part-time or non-covered employees may also offer the program.
Applications are available online at www.novadiabetes.com or phone the office 9am-5pm M-F at 901-384-4774.
###
Press Contact: Paul Boston Company Name: NOVA GROUP OF MEMPHIS, INC. Email: email protected from spam bots Phone: 901-384-4774 Website: email protected from spam bots
Medicinal Plants and Traditional Medicine Suject Of New Online Journal
New Online Journal Explores Medicinal Plants and Traditional Medicine
Free forum will expand global knowledge about beneficial plants and trees.
Wichita, KS (PRWEB) February 8, 2006 -- A new online scientific journal focused on traditional knowledge and scientific studies of beneficial plants launched this month, announced Balbir Mathur, president of the non-profit Trees for Life. Trees for Life Journal: A forum on beneficial trees and plants will be a free, open access electronic forum, to bring together international articles about traditional medicine, small-scale field studies and scientific evidence regarding natural remedies and medicinal plants that could benefit humanity. The journal is available online at www.tfljournal.org.
Our journal aims to bridge the gap between grassroots knowledge and scientific research, Mathur said. By publishing formal and informal studies on medicinal plants and trees and the resulting herbal remedies, we hope to advance the use of these vital resources worldwide.
Trees for Life is a non-profit organization that helps plant fruit trees in developing countries as a low-cost, self-renewing food source. The movements philosophy of education, health and environment will be evident in Trees for Life Journal, which aims to expand global knowledge about the medical and nutritional value of plants in order to educate citizens of third world countries.
The idea for the journal was born from traditional claims about the nutritional, medicinal and other beneficial properties of the tree Moringa oleifera. Every part of the tree is edible or used as traditional medicine, from the leaves to the bark to the seeds. It grows wild in poor soil and provides vitamins desperately lacking in diets of impoverished people. Trees for Life recognized the need for a forum to publish and discuss scientific studies and communal knowledge of this tree, in order to promote its cultivation in the developing world. The inaugural issue of the journal includes a review of the medical evidence for Moringas potential.
People whose lives could be improved by research findings are not even aware such a wealth of information exists in their midst, said Mathur. Almost anyone with experience would agree that many more channels of communication are needed to increase the exchange between academics and lay people.
Trees for Life Journal will be free to users and features an easy-to-use format. Anyone may publish an articlefrom peer-reviewed field and clinical studies to informal essays or ideas for possible new uses of medicinal plants and trees. The content is also freely available for reproduction and distribution, with credit given to the original authors. The Web site also features a mentor program that matches experienced scientists with those who are new to the research process. Publishing electronically means the journal can be updated as often as necessary.
The ease and speed of this technology transcends the barriers of cost, space and time, Mathur said. Thanks to the Web, it is now possible to scale the walls that have long divided those who know and those who need the knowledge.
Dr. Doren Fredrickson of the University of Kansas School of Medicine-Wichita will be the journal's Chairman. Dr. Jed Fahey of Johns Hopkins University School of Medicine will be Editor-in-Chief and Jeffrey Faus of Trees for Life will be Managing Editor.
About Trees for Life: Founded in 1984 by Wichita businessman Balbir Mathur, Trees for Life is an international nonprofit movement that demonstrates that by helping each other, people can unleash extraordinary power that enriches every life. Their mission is to create hope through a movement in which people join hands to break the cycle of poverty and hunger and care for our earth. For more information about the Trees for Life organization, visit www.treesforlife.org.
Contact: Jeffrey Faus Trees for Life 3006 W. St. Louis Wichita, KS 67203-5129 316-945-6929
# # #
Press Contact: Jeffrey Faus Company Name: Trees for Life Email: email protected from spam bots Phone: 316-945-6929 Website: www.tfljournal.org
Introducing a New Online Pharmacy Comparison Shopper
Press Release by: Pharmacy Scout
Published on openPR 02-06-2006 09:48 am - CET
(openPR) - Introducing Pharmacy Scout, a New Online Pharmacy Comparison Shopper
Pharmacy Scout is excited to announce the launch of their free online comparison shopper, connecting customers with online Canadian and overseas pharmacies.
With today's high price of prescription medication, more Americans are looking to the Internet to find bargains at Canadian and overseas pharmacies. This option is especially attractive to the growing senior population and the record number of Americans who can't afford prescription coverage.
In the last several years, the number of online pharmacies has increased rapidly. Pharmacy Scout recognizes the need for a one-stop resource where consumers can research dozens of these pharmacies, and find the right medication at the right price -- with only a few clicks of the mouse.
And to make sure you find the safest and most reliable online pharmacies in your search, Pharmacy Scout reviews and rates every business in our database.
Powerful, Fast, and Easy-to-Use Technology
When the development team at Pharmacy Scout built their search technology, they placed extra emphasis on the speed and accuracy of the results.
Pharmacy Scout allows users to simultaneously search dozens of pharmacy Web sites and get results in less than thirty seconds, even for users with slower dial-up internet connections. You'll get the most up-to-date price quotes as well. If the price of a prescription drug changes on one of the pharmacy websites in the Pharmacy Scout database, the price change is instantaneously reflected in your search results.
Search results appear in a clean, easy-to-understand layout. You'll receive the pharmacy name and contact information, the price of your medication, the dosage, the quantity in which it's sold, and ratings for that pharmacy. For personalized convenience, users can also receive an email notification when the price of a particular medication drops.
Pharmacy Scout, established in 2004, provides online shoppers with a free, robust, easy to use search tool for Canadian and overseas pharmacies. Visit Pharmacy Scout at http://www.pharmacyscout.com.
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
EPA Asbestos Ban Overturned To Allow Continued Asbestos Use in USA
Asbestos Still Being Used In USA, Despite The Known Risks
Category: Public Health News Article Date: 06 Feb 2006 - 16:00pm (UK)
The February edition of CancerWire focuses on the continued presence of a carcinogen that will stun many Americans - asbestos the well known carcinogenic mineral is still being used in the U.S. and this deadly mineral can be found in over 30 million homes and schools. These revelations and others were provided during a recent interview with Linda Reinstein of the Asbestos Disease Awareness Organization (ADAO).
Asbestos Diseases are Incurable
When her husband Alan was diagnosed with a deadly cancer (mesothelioma) which is caused by asbestos, Linda Reinstein decided to take a stand. She turned her anger into action and co-founded the Asbestos Disease Awareness Organization (ADAO). Today, ADAO is an international organization that has representatives throughout the world and offers support, resources and education for a growing community of patients and caregivers.
Ms. Reinstein wants more Americans to know about asbestos so they can protect themselves and avoid being diagnosed with an incurable disease like her husband. Asbestos can cause or contribute to cancers such as mesothelioma, lung, larynx, esophageal, and stomach cancer and many non-malignant diseases such as asbestosis and chronic pulmonary respiratory disease. Ten thousand lives are lost in the U.S. every year to all asbestos-related disease. Each case is incurable and often deadly and every case could have been prevented because the dangers of this mineral were known in the early 1900's, Ms. Reinstein explained. This enormous death toll may actually be under-reported because asbestos diseases are usually hard to diagnose. Many victims will die of cardiac failure or pneumonia and are never diagnosed with an asbestos related disease.
No Asbestos Ban?
In 1989, the EPA announced an asbestos ban and phase out. But in 1990, the ban was overturned by a U.S. Circuit Court of Appeals. So we don't have an actual ban on asbestos, but instead a regulation to reduce exposure, said Reinstein. Asbestos is allowed in certain concentrations. For example, under OSHA, an employee cannot be exposed to more than 0.1 asbestos fibers per cubic centimeter of air for an average eight hour work day. But, this gets confusing because how does a consumer know if a given product fits within those guidelines? According to Reinstein these regulations may not even matter because the EPA has repeatedly stated that there is no safe level of asbestos exposure.
In addition to having asbestos present in new products and materials, an estimated 30 million homes, schools and offices are already contaminated with the mineral. So construction, repair, or demolition in older structures can lead to exposure as we saw on 9/11 with the World Trade Center. One life lost to an asbestos related disease is tragic; hundreds of thousands of lives lost is unconscionable. While we can't reclaim the lives of our loved ones, we can make the world a better place for those who come after us. Reinstein concluded.
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
New Search and Email Marketing Research Results & CRM Magazine
CRM Magazine & New Search and Email Marketing Research Results
We are sending you this offer because you have subscribed to similar Sales & Marketing Publications in the past. As such, we wanted to give you the chance to subscribe to CRM Magazine and also to sign up to read NetLine's White Paper - New Search and email Marketing Research Results.
Be sure to forward this email to business associates - they may wish to apply to receive a complimentary publication in their industry as well.
CRM Magazineaims to assist senior managers to identify how to maintain and gain profitable customers, generate loyalty and reduce business costs.
Browse the list of job functions and industries on the application form to see if you might qualify. Also note the geographic availability. Then simply complete the form and submit it.
If you have co-workers, friends or family who work in a related field, please pass this offer on to them - they'll thank you!
Cheers,
Gina Geertz TradePub.com Manager
16795 Lark Ave, Los Gatos, 95032
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
One rare form of cancer is called Mesothelioma, a malignant tumor in the mesothelial tissues of the lungs and the abdomen, arising from the inhalation of asbestos. Its rarity is one of the reasons why a lot of people are not aware of this kind of fatal disease. In fact, many people die of Mesothelioma undiagnosed. Although there is now a growing awareness of the hazards of asbestos to health, still many have not heard of Mesothelioma and thus, have not understood its nature, cause, signs and treatment. Even some physicians find it hard to detect Mesothelioma because its symptoms are akin to other diseases like lung cancer and pneumonia. Furthermore, it takes decades for a patient who was exposed to asbestos to develop Mesothelioma fifty years, at most.
Being unaware of Mesothelioma poses higher risks since it deters diagnosis and treatment. A person undergoing treatment must know the different stages of the cancer or the extent of the disease. Chances of recovering from Mesothelioma and the kind of treatment depend on the stage of the illness. There are basically two staging systems used for Pleural Mesothelioma (lungs): TNM system and Brighan system. These staging systems are also used in other kinds of cancers; however, the first is commonly used. There is no established method in determining the stage of the Peritoneal Mesothelioma cancer (abdominal) so the TNM system is used.
There are three variables in the TNM system: tumor, lymph nodes and metastasis. In the earliest stage of Mesothelioma, stage I, the malignant Mesothelioma cells start to grow and multiply only one layer of the pleura. The pleura is the membrane that encloses the lungs and lines the wall of the chest cavity. However, there are some instances wherein the pericardium (membrane that covers the heart) and diaphragm cover are already affected. In this case, the cancer patient is still in stage I Mesothelioma.
In the second stage, the two layers of the pleura are already affected by Mesothelioma. Take note, however, that in this stage, only one side of the body is affected. Normally, the pleura produces only small amount of lubricating fluid that allows easy expanding and contracting of the lungs. The excess fluid is absorbed by the blood and the lymph vessels so theres a balance between the amount of fluid produced and removed. During the second stage Mesothelioma, fluid starts to build up between the membrane of the lungs and the membrane of the chest wall, resulting to pleural effusion. The increase in the volume of fluid produced causes shortness of breath and chest pain. Other Mesothelioma cancer patients experience dry and persistent cough. Diagnosis of the pleural effusion is achieved through a chest x-ray.
Stage III Mesothelioma means that the malignant cells have already spread to the chest wall, esophagus and the lymph nodes on one part of the chest. The patient may suffer severe pain near the parts affected. When not treated immediately or when the Mesothelioma patient doesnt respond well to medication, the cancer may advance to the fourth stage. The fourth stage Mesothelioma is formidable since at this stage the Mesothelioma cells have penetrated into the bloodstream and other organs in the body like the liver, the bones and the brain. The lymph nodes on the other side of the chest may also be affected by Mesothelioma in stage IV.
Brighan staging system, on the other hand, determines whether the Mesothelioma can be surgically removed or not and whether the lymph nodes are affected or not. In stage I Mesothelioma, the lymph nodes are not yet affected and the patient can still recover through surgery. In stage II, surgery can still be executed but some lymph nodes have already been infiltrated by the cancer cells. In stage III, the heart and chest wall are already affected; thus, surgery is no longer advisable. The lymph nodes in this stage, however, may or may not be affected. In the final stage, stage IV Mesothelioma, cancer cells have already gone to the bloodstream and other parts of the body like the heart, brain, bone and liver. In most cases, a patient who has reached stage IV Mesothelioma only has four to twenty-four months to live.
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
An exciting new treatment that has given hope to mesothelioma victims is called gene therapy. Gene therapy attempts to decipher why proteins within certain cells cause them to be resilient to cancer while some cells do not. A while back it was believed that genes were complete upon birth, and that they couldnt affect conditions afflicted during life. This however, turned out to not be the case. Since then we have learned that smoking, sunlight and certain foods can all affect our DNA and make changes to our genetic code. These new insights provided by these conditions have allowed doctors to view many conditions like malignant mesothelioma in a new light.
There are many factors that contribute to Mesothelioma. Asbestos exposure is the primary contributing factor, but genetic mutations in individuals also worsen it. Gene therapy is a revolution in mesothelioma treatment because it replaces cancer-causing genes with genes that are medically constructed to die when exposed to cancerous growth. These suicide genes are a possible way to slow and possibly stop the rapid replication of cancerous cells. Studies are also starting to begin experimenting with replacing cancer generating genes with genes susceptible to certain drugs. This would allow the cancer to be potentially eliminated with few side effects.
Gene therapy treatment is still in its beginning stages and is not yet 100% safe. However, this desperate situation suffered by mesothelioma victims, sometimes calls for various experimental treatments. Any hope for surviving mesothelioma outweighs many of the dangers involved.
This article may be freely reprinted as long as this resource box is included and all links stay intact as hyperlinks. For more information on mesothelioma and mesothelioma litigation, please visit http:///www.resource4mesothelioma.com
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
In general, mesothelioma is a rare form of cancer. Different types of mesothelioma are distinguished between by where the cancer is growing. Pleural mesothelioma, the most common, accounting for 75% of all mesothelioma cases, is where cancerous cells develop on the lining of the lungs. The next most common form of mesothelioma is peritoneal mesothelioma and this is where cancerous cells grow on the peritoneum which is the lining of the abdomen. Pericardial mesothelioma, the least common major form of mesothelioma, makes up roughly 5% of all mesothelioma cases. This is where malignant cancer cells grow on the lining of the heart.
All three of these forms of mesothelioma are caused by asbestos. Asbestos is a naturally occurring fibrous mineral that was discovered around the 1860s. Due to its highly useful property of being fireproof, asbestos was used greatly in construction in the 1920s, 1930s and 1940s. It was not until the early 1960s when the severe health hazards that asbestos causes were discovered, that asbestos stopped being used. When exposed to asbestos with insufficient protection a person will breathe in tiny asbestos fibres which are suspended in the air. These fibres pass into the respiratory system until they become lodged in the lining of the lungs. Over time, an accumulation of these asbestos fibres in the lungs can cause pleural mesothelioma. Asbestos fibres may also pass into the lymphatic system and be transported to either the lining of the abdomen or the tissue surrounding the heart. This may cause either peritoneal mesothelioma or pericardial mesothelioma.
In terms of symptoms, the three main types of mesothelioma have some symptoms in common with each other. These symptoms are usual of all three types: chest pain, shortness of breath, coughing, coughing up blood, vomiting, nausea, weight loss and loss of appetite. An additional symptom of pericardial mesothelioma is palpitations.
There are a few treatments for all types of mesothelioma but none of these have a high success rate. The effectiveness of the treatment depends on how early and how aggressively the cancer is treated. If the cancerous cells are treated when they have fully matured and developed then it is unlikely that treatment methods will be successful. Treatment methods include chemotherapy which is the use of drugs to kill the cancer, radiation therapy which uses a radiation dosage to kill off cancerous cells and surgery which attempts to gain long term control over the cancer by removing a large portion of malignant cells. These treatment methods can be combined in the form of dual therapy.
For more information on pericardial mesothelioma such as the risks, causes, symptoms and treatments go to:
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
One rare form of cancer is called Mesothelioma, a malignant tumor in the mesothelial tissues of the lungs and the abdomen, arising from the inhalation of asbestos. Its rarity is one of the reasons why a lot of people are not aware of this kind of fatal disease. In fact, many people die of Mesothelioma undiagnosed. Although there is now a growing awareness of the hazards of asbestos to health, still many have not heard of Mesothelioma and thus, have not understood its nature, cause, signs and treatment. Even some physicians find it hard to detect Mesothelioma because its symptoms are akin to other diseases like lung cancer and pneumonia. Furthermore, it takes decades for a patient who was exposed to asbestos to develop Mesothelioma fifty years, at most.
Being unaware of Mesothelioma poses higher risks since it deters diagnosis and treatment. A person undergoing treatment must know the different stages of the cancer or the extent of the disease. Chances of recovering from Mesothelioma and the kind of treatment depend on the stage of the illness. There are basically two staging systems used for Pleural Mesothelioma (lungs): TNM system and Brighan system. These staging systems are also used in other kinds of cancers; however, the first is commonly used. There is no established method in determining the stage of the Peritoneal Mesothelioma cancer (abdominal) so the TNM system is used.
There are three variables in the TNM system: tumor, lymph nodes and metastasis. In the earliest stage of Mesothelioma, stage I, the malignant Mesothelioma cells start to grow and multiply only one layer of the pleura. The pleura is the membrane that encloses the lungs and lines the wall of the chest cavity. However, there are some instances wherein the pericardium (membrane that covers the heart) and diaphragm cover are already affected. In this case, the cancer patient is still in stage I Mesothelioma.
In the second stage, the two layers of the pleura are already affected by Mesothelioma. Take note, however, that in this stage, only one side of the body is affected. Normally, the pleura produces only small amount of lubricating fluid that allows easy expanding and contracting of the lungs. The excess fluid is absorbed by the blood and the lymph vessels so theres a balance between the amount of fluid produced and removed. During the second stage Mesothelioma, fluid starts to build up between the membrane of the lungs and the membrane of the chest wall, resulting to pleural effusion. The increase in the volume of fluid produced causes shortness of breath and chest pain. Other Mesothelioma cancer patients experience dry and persistent cough. Diagnosis of the pleural effusion is achieved through a chest x-ray.
Stage III Mesothelioma means that the malignant cells have already spread to the chest wall, esophagus and the lymph nodes on one part of the chest. The patient may suffer severe pain near the parts affected. When not treated immediately or when the Mesothelioma patient doesnt respond well to medication, the cancer may advance to the fourth stage. The fourth stage Mesothelioma is formidable since at this stage the Mesothelioma cells have penetrated into the bloodstream and other organs in the body like the liver, the bones and the brain. The lymph nodes on the other side of the chest may also be affected by Mesothelioma in stage IV.
Brighan staging system, on the other hand, determines whether the Mesothelioma can be surgically removed or not and whether the lymph nodes are affected or not. In stage I Mesothelioma, the lymph nodes are not yet affected and the patient can still recover through surgery. In stage II, surgery can still be executed but some lymph nodes have already been infiltrated by the cancer cells. In stage III, the heart and chest wall are already affected; thus, surgery is no longer advisable. The lymph nodes in this stage, however, may or may not be affected. In the final stage, stage IV Mesothelioma, cancer cells have already gone to the bloodstream and other parts of the body like the heart, brain, bone and liver. In most cases, a patient who has reached stage IV Mesothelioma only has four to twenty-four months to live.
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles. However, they may have been been exposed to asbestos dust and fibre in other ways. This could include working with asbestos or by home renovation using asbestos cement products or even by washing the clothes of a family member who worked with asbestos. The resulting disease is rare form of cancer in which malignant (cancerous) cells are found in the mesothelium, a protective sac that covers most of the body's internal organs.
Mesothelioma occurs more often in men than in women and risk increases with age, but this disease can appear in either men or women at any age. About 2,000 new cases of mesothelioma are diagnosed in the United States each year. Although reported incidence rates have increased in the past 20 years, mesothelioma is still a relatively rare cancer.
There are various procedures used for the treatment of mesothelioma. The type of treatment depends on the location of the cancer, the stage of the disease, and the patient's age and general health.
A common treatment of the disease is by means of surgery by the removal of part of the lining of the chest or abdomen and some of the tissue around it. For cancer of the pleura, a lung may be removed in an operation called a pneumonectomy. Sometimes part of the diaphragm, the muscle below the lungs that helps with breathing, is also removed.
Another method is Radiation therapy, also called radiotherapy. This involves the use of high-energy rays to kill cancer cells and shrink tumors. Radiation therapy affects the cancer cells only in the treated area. The radiation may come from a machine or from putting materials that produce radiation through thin plastic tubes into the area where the cancer cells are found .
Anticancer drugs can be used to kill cancer cells throughout the body. This is known as chemotherapy and involves the administration of the drugs by injection into a vein (intravenous, or IV). Currently, doctors are also studying the effectiveness of putting chemotherapy directly into the chest or abdomen.
Because mesothelioma is very hard to control, the U.S. National Cancer Institute (NCI) is sponsoring clinical trials that are designed to find new treatments and better ways to use current treatments
About The Author
Looking for information about Mesothelioma? Go to: http://www.mesotheliomalegalreview.com 'Mesothelioma Legal Review' is published by Linda Woodhouse - The complete resource directory for Mesothelioma related information, legal services, and products Check out more Mesothelioma articles at: http://www.mesotheliomalegalreview.com/archive
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
Mesothelioma is a form of cancer located in the lining of either the lungs, abdomen or the heart. These linings are thin layers of tissue covering the organ.
The pleura is the tissue covering the lungs and the wall of the chest cavity which cushions and protects the lungs. The peritoneum lines the abdominal wall and surrounds most of the organs in the abdomen. The pericardium is the tissue surrounding the heart.
Mesothelioma is a rare but very serious cancer. There are three types of mesothelioma based on the types of cancerous cells. The most common type is epithelioid and consists of 50-70% of total cases and has the best prognosis. The second type is called sarcomatoid, consists of 10-20 % of mesothelioma cases and is more unpredictable in nature. The third type of mesothelioma is called biphasic, it is a combination of the other two types and consists of 20-35% of all cases.
There are an estimated 2000-3000 new cases of mesothelioma in the United States every year. The majority of these cases begin in the chest wall (pleural mesothelioma), a few start in the abdomen (peritoneal mesothelioma) and very rare are the cases starting in the lining surrounding the heart (pericardial mesothelioma).
The pleura is a thin lining of mesothelial cells. There are two pleuras in the chest, the parietal pleura and the visceral pleura. The parietal pleura lines the chest wall including the inside of the ribs, diaphragm and pericardium. The visceral pleura covers the lungs and filters fluid to and from the chest. If the pleura becomes diseases it is not effective at eliminating fluid from the chest resulting in pleural effusion or too much fluid in the chest.
Mesothelioma is usually the result of exposure to asbestos. Most people who are diagnosed with mesothelioma have had jobs where they breathed asbestos fibers. It may take up to 60 years from the time of asbestos exposure until mesothelioma develops.
Although rare, mesothelioma is a serious form of cancer which is often in its advanced stage when a diagnosis is made. In general, prognosis for mesothelioma patient is poor, however, some patients live with the disease for a long time. As mentioned earlier, the type of mesothelioma has an impact on the prognosis, as well as, the age of the patient, how much tumor has developed and if treatment is rendered. There are many variables in evaluating a mesothelioma case, so only the patients doctor can determine the best treatment and possible prognosis on an individual basis.
About The Author
Jill Kane provides useful information and resources regarding mesothelioma and asbestos at www.mesothelioma-101.org.
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
Pericardial mesothelioma is a rare form of mesothelioma that accounts for roughly 5% of all mesothelioma cases. Pericardial mesothelioma is a cancer that grows on the lining of the heart. The lining of the heart is extremely important because it plays an important role in protecting the heart from damage and so pericardial mesothelioma is an extremely serious condition. Pericardial mesothelioma becomes a terminal illness if not treated aggressively in its early stages.
Like all other forms of mesothelioma, pericardial mesothelioma is caused by inhalation of asbestos dust and fibres. Once inhaled, asbestos fibres become lodged in the lungs. From the lungs, the fibres can either pass into the lymphatic system and then be transported to the lining of the lungs or they can gradually move across to the lining of the heart over a long period of time. Over a long period of time, asbestos fibres can accumulate on the lining of the heart and this is when pericardial mesothelioma becomes a likelihood. Due to the fact that asbestos is still present in many public buildings, the possibility of pericardial mesothelioma is a reality for everyone, although for most, very unlikely.
Those with the highest chance of having mesothelioma are those who have been in constant contact with mesothelioma for a length of time as short as a few months. These are people like construction workers and asbestos manufacturers. Those who are in contact with people who are constantly exposed to asbestos are also at risk due to the fact that asbestos fibres can stick to clothes and hair and so can be carried around.
Presently, cases of mesothelioma are increasing including pericardial mesothelioma. Elderly men who are approaching 60 - 70 years of age are just starting to suffer from pericardial mesothelioma due to its long latency period (amount of time the symptoms take to show) of 30 - 50 years. They are suffering because this was the generation who worked with asbestos and amongst asbestos when asbestos was an extremely popular building material in the 1950s 1970s. These men are now lodging multi-million dollar lawsuits against the companies who exposed them to the dangers of asbestos.
Pericardial mesothelioma has a number of symptoms but these only start to take effect in the cancers latest stages when it is almost fully matured and developed. These symptoms include persistent coughing, shortness of breath, chest pains and palpitations. Other symptoms typical of all types of mesothelioma include loss of appetite, nausea and weight loss. What often makes pericardial mesothelioma so difficult to treat is that its symptoms are typical of many other more common diseases such as pneumonia. To be treated effectively, pericardial mesothelioma needs to be treated aggressively in its early stages and so many patients treatments are given too late because of a delay in diagnosis.
Treatments for pericardial mesothelioma are very limited and as yet, success rates for curing pericardial mesothelioma are very low. The chances of a patients survival depend largely on how early the cancer is treated and how aggressively. Treatment methods include chemotherapy, radiation therapy, dual therapy and surgery. Chemotherapy uses drugs to try to kill off cancerous cells. Radiation therapy uses radiation to try to kill off cancerous cells although this is extremely difficult in the case of pericardial mesothelioma because too much radiation can badly damage the heart.
Dual therapy is a combination of both chemotherapy and radiation therapy. Surgery comes in two different types, aggressive surgery and palliative procedures. Aggressive surgery is only used on the strongest of patients such as young and healthy men and consists of removing a large portion of the cancer and attempts to gain control over the cancer. Palliative procedures are a more passive way of dealing with pericardial mesothelioma and just attempts to relieve the patient of the symptoms.
Research is being done into pericardial mesothelioma in research stations all over the USA and many pharmaceutical companies are also attempting to find new drugs for chemotherapy. So far, much research has been unsuccessful.
For more information on pericardial mesothelioma such as the risks, causes, symptoms and treatments go to:
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
Duragesic Transdermal Patch, Fentanyl Pain Patch Linked to Overdose Deaths
Overdose Deaths Linked to Fentanyl Pain Patch Being Investigated By Jersey Law Firm
Press Release by: Bagolie Friedman Injury Lawyers
Published on openPR 02-01-2006 09:09 am - CET
(openPR) - Jersey City, New Jersey February 2006 - The New Jersey, USA Offices of Bagolie Friedman Injury Lawyers are investigating overdose deaths linked to the fentanyl pain patch. Known as the Duragesic Transdermal Patch, it is a device developed to alleviate chronic pain which could possibly leak, exposing patients to dangerous levels of fentanyl, a powerful opiate based pain reliever.
The fentanyl patch is comprised of an outer impermeable plastic shell and a drug permeable inner lining. The patch is applied directly to the skin where heat from the body activates a regular release of fentanyl over a 72 hour period. This drug is a powerful opiate pain-reliever held in a gel suspension between the two linings of the patch. The inner lining only lets a certain amount of the drug into the body based on the needs of the patient, typically between 25 to 100 micrograms per hour. Sales of Duragesic earned Janssen Pharmaceutica over a billion dollars between the year 2002-2003. Unfortunately a problem in the seal between the linings was discovered in February 2004, prompting Janssen to initially recall one group of the patches, but an additional four groups of the patch were removed from the market later in April. The company has since recalled over two million of the patches.
Bagolie Friedman Injury Lawyers, with affiliate offices in Jersey City and Clifton New Jersey, Hollywood Florida and Brisbane, Australia, have begun to review and accept injury cases from surviving family members and individuals who have suffered from Fentanyl overdose. "We will be reviewing potential cases from the United States, Australia and Europe," said founding partner, Ricky Bagolie.
Duragesic is no longer the only fentanyl pain patch being marketed. On January 28, 2005, the U.S. Food and Drug Administration (FDA) granted final approval for Mylan Laboratories, Inc. to market a generic fentanyl transdermal system. The manufacturer of Duragesic® has also begun to market an authorized generic version of the fentanyl patch through an agreement with Sandoz. Other generic companies have applications pending at the FDA to market similar fentanyl patches, therefore, other generic versions may soon be available. Problems associated with these newer generic patches have also been reported. "It is very difficult for a person examining a fentanyl patch to detect a defect or leak. This can lead to a dangerous situation as exposure to an excessive amount of fentanyl can lead to serious injury or death." says attorney Alan Friedman.
If you believe that you, or a member of your family, has been injured or suffered from an overdose as a result of receiving a fentanyl pain , contact Ricky Bagolie or Alan Friedman toll free at 1-866-333-3529, e-mail them at info@bagoliefriedman.com or visit http://www.bagoliefriedman.com now for a confidential and free consultation.
Probiotics Can Help Before, During and After Antibiotic Therapy
Probiotics Can Help Before, During and After Antibiotic Therapy
In a recent CNN report discussed AAD, or Antibiotic-Associated Diarrhea, a concern for anyone that is prescribed antibiotics to combat any type of infection was discussed. AAD occurs when antibiotics destroy too many of the "good" bacteria in your intestinal tract, causing harmful bacteria to run rampant far beyond their normal numbers.
Walnut Creek, CA (PRWEB) February 2, 2006 -- Nebraska Cultures, leading the probiotic industry for the past 25 years, is reinforcing their commitment to consumer education when it comes to probiotics and their use during antibiotic therapy. In a recent CNN report discussed AAD, or Antibiotic-Associated Diarrhea, a concern for anyone that is prescribed antibiotics to combat any type of infection was discussed.
AAD occurs when antibiotics destroy too many of the "good" bacteria in your intestinal tract, causing harmful bacteria to run rampant far beyond their normal numbers. The results frequent watery bowel movements. No laughing matter, AAD is a potentially serious condition that affects up to 20 percent of people receiving antibiotic therapy. It has been shown that taking the right probiotic supplements during antibiotic therapy can help to prevent or lessen the effects of AAD.
Probiotics refers to concentrated supplements of beneficial bacteria similar to those that occur naturally in a healthy intestinal tract. Probiotic supplements are concentrated, beneficial bacteria formulated to survive the highly acidic digestive process in your stomach and propagate in the intestines. Probiotic foods are also a good source of beneficial bacteria to help with AAD. Yogurt is one of the simple and delicious functional foods that can help to curb the side effects of antibiotic therapy.
In the recently released book by Dr. Khem Shahani, Cultivate Health from Within: Dr. Shahanis Guide to Probiotics, states, "It has been known for nearly a century that eating fermented foods containing friendly bacteria has important nutritional and therapeutic benefits in proper friendly bacteria balance proper balance of friendly bacteria is not an easy feat to accomplish. Diets rich in sugar, cortisone and cortisone-like drugs, birth control pills, immuno-suppressive drugs and antibiotics have been major culprits in affecting a naturally healthy digestive system and overall body health."
Thats precisely the reason Dr. Shahani wrote Cultivate Health From Within. He sensibly describes which probiotics are instrumental in achieving and maintaining the bodys health. Dr. Shahanis® DDS-1 strain of L. acidophilus and other probiotics greatly help the body in healing and maintaining good health now and always.
# # #
Press Contact: Angelica Jones Company Name: JONES INT'L Email: email protected from spam bots Phone: 909-336-9494 Website: www.drshahani.com
Cancer Association Honors Dr. Jacob Rowe for Stem Cell Transplant Research
Israel Cancer Association USA Honors Dr. Jacob Rowe of Rambam Medical Center in Haifa for Stem Cell Transplant Research
Gala to be held February 2 at Trumps Mar-A-Lago on Palm Beach.
Palm Beach, FL (PRWEB) February 1, 2006 -- The Israel Cancer Association USA Annual Gala 2006 will be honoring Dr. Jacob M. Rowe of the Rambam Medical Center in Haifa on Palm Beach as the recipient of the Emanuel G. Rosenblatt Award for Scientific Achievement. On Thursday, February, 2, Dr. Rowe will be available for media interviews via phone prior to the Gala to discuss the impact that the Israel Cancer Association has had on his work and the opportunities afforded to him by generous donations from residents of Palm Beach. To schedule an interview please contact AJR&Partners at 305.665.5755.
The Gala, co-chaired by Roy Apple, Lee Goldstein, Celia Jacobs and Deena Morgan, will also be honoring Peter Brown, President of the ICA USA for the past four years, and his wife Nancy. The Browns, who reside in Palm Beach, Florida, Alpine, New Jersey, and East Hampton, New York, are being recognized for their untiring commitment and generous support for cutting edge cancer research in Israel. It was a unanimous decision that Peter and Nancy Brown be our honorees this year, stated Roy Apple, Co-Chair of Gala 2006. They have both been an integral part of our Israel Cancer Association family since its inception and have consistently demonstrated their generosity and commitment to helping Israel find cures for cancer.
For the past seven years the Israel Cancer Association USA has recognized an outstanding cancer research scientist, to receive the Emanuel G. Rosenblatt Award for Scientific Achievement. This years recipient is Dr. Jacob M. Rowe, Chief of the Department of Hematology and Bone Marrow Transplantation at the Rambam Medical Center in Haifa.
Dr. Rowe is responsible for establishing a major Stem Cell Transplant Unit at Rambam Medical Center and revitalized the Hematology Department, significantly improving the level of care for patients with Hematologic diseases. Past recipients of this award included Nobel Prize winner Dr. Aaron Ciechanover from Technion in Israel and Dr. Judah Folkman, of Harvard University Medical School in Boston, Massachusetts.
The Israel Cancer Association is involved on all fronts in the fight against cancer, supporting research and services in over 30 hospitals and research institutions throughout Israel. Israel has the unlimited ability to conduct stem cell research, which most oncologists believe is the key to finding cures.
Contact Information Alec Rosen 305.665.5755 alecjr-at-ajrpartners.com David Gil david-at-ajrpartners.com
Israel Cancer Association www.icausa.org 561.832.9277
# # #
Press Contact: Alec Rosen Company Name: AJR & PARTNERS Email: email protected from spam bots Phone: 305.665.5755 Website: www.icausa.org
_______________________________________________________ Free trade and professional industry magazines are available at http://www.consultant-directory.tradepub.com _______________________________________________________ Lung Cancer caused by asbestos exposure is known as Mesothelioma. Learn more about this killer cancer. Visit http://www.Mesothelioma-Search-Engine.com _______________________________________________________
